Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.49 USD | 0.00% | -4.88% | -19.57% |
Jun. 05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.57% | 210M | |
+29.97% | 451B | |
+34.52% | 280B | |
+11.33% | 138B | |
+8.34% | 92.55B | |
+26.70% | 91.02B | |
+71.32% | 64.41B | |
+15.19% | 45.22B | |
+23.39% | 35.71B | |
-11.89% | 31.89B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Barclays Starts OptimizeRx With Equalweight Rating, $15 Price Target